E-LIB Suche - Ergebnisse für: Hess, Brian J.

1

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology. , 2024

2

Distribution and suitability of pulmonary surfactants as a ..:

Barlang, Lea-Adriana ; Deimel, Isabelle ; Mohl, Björn-Patrick...
European Journal of Pharmaceutical Sciences. 196 (2024) - p. 106744 , 2024

Link: https://doi.org/10.1016/..

3

Impact of race and social determinants of health on outcome..:

Karmali, Reem ; Machhi, Rushad ; Epperla, Narendranath...
Blood Advances. 8 (2024) 10 - p. 2592-2599 , 2024

Link: https://doi.org/10.1182/..

4

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S33-S34 , 2024

Link: https://doi.org/10.1016/..

5

Subsequent malignant neoplasms in patients previously treat..:

Melody, Megan ; Epperla, Narendranath ; Shouse, Geoffrey...
Blood Advances. 8 (2024) 10 - p. 2327-2331 , 2024

Link: https://doi.org/10.1182/..

6

Outcomes of patients with secondary central nervous system ..:

Epperla, Narendranath ; Feng, Lei ; Shah, Nirav N....
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Prognostic value of early positron emission tomography in p..:

Crombie, Jennifer L. ; Jacobson, Caron A. ; Redd, Robert...
Haematologica. 108 (2023) 12 - p. 3433-3437 , 2023

Link: https://doi.org/10.3324/..

8

Peri–CAR-T practice patterns and survival predictors for al..:

Zurko, Joanna ; Nizamuddin, Imran ; Epperla, Narendranath...
Blood Advances. 7 (2023) 12 - p. 2657-2669 , 2023

Link: https://doi.org/10.1182/..

9

Clinical outcomes of older and younger patients treated wit..:

Hamadani, Mehdi ; Spira, Alexander ; Zhou, Xiaolei...
Blood Advances. 8 (2023) 1 - p. 93-98 , 2023

Link: https://doi.org/10.1182/..

10

Loncastuximab tesirine in relapsed/refractory diffuse large..:

Caimi, Paolo F. ; Ai, Weiyun Z. ; Alderuccio, Juan Pablo...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

11

ABCL-134 Phase Ib Open-Label Study of Loncastuximab Tesirin..:

Hess, Brian ; Solh, Melhem ; Gandhi, Mitul...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S419 , 2023

Link: https://doi.org/10.1016/..

12

Use of adhesive cranial bone flap fixation without hardware..:

Smith, Timothy R. ; Foley, Kevin T. ; Boruah, Sourabh...
Journal of Neurosurgery. 139 (2023) 2 - p. 517-527 , 2023

Link: https://doi.org/10.3171/..

13

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere. 7 (2023) S3 - p. e402511c , 2023

Link: https://doi.org/10.1097/..

14

POSTER: ABCL-134 Phase Ib Open-Label Study of Loncastuximab..:

Hess, Brian ; Solh, Melhem ; Gandhi, Mitul...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S208 , 2023

Link: https://doi.org/10.1016/..

15

Novel high–risk acute myeloid leukemia subgroup with ERG am..:

Schandl, Cynthia A. ; Mazzoni, Sandra ; Znoyko, Iya...
Cancer Genetics. 272-273 (2023) - p. 23-28 , 2023

Link: https://doi.org/10.1016/..